Common bone-loss drug Fosamax may guard against new-onset diabetes, national study finds
By
Alicia Lasek
Oct 04, 2021
Participants taking alendronate were 36% less likely to have new-onset type 2 diabetes than their peers who did not take the drug, according to a large, 10-year study in Denmark.
Diabetes and obesity drugs reduce COVID-19 complications, analysis shows
By
Alicia Lasek
Sep 28, 2021
Diabetes type 2 is linked to severe COVID-19 illness, but a type of drug used to improve glycemic control and weight loss may also reduce complications from the viral disease, a new study finds.
DPP-4i use may protect in Alzheimer dementia with diabetes
Aug 12, 2021
Low amyloid burden and favorable cognitive outcomes seen with DPP-4i use in Alzheimer disease-related cognitive impairment with diabetes
Diabetes drug turned weight loss med spurs cost-benefit concerns for docs
By
Alicia Lasek
Aug 13, 2021
The high price tag and lack of coverage for high-performing anti-obesity drug Wegovy begs the question of what the benefits of weight loss are worth to insurers and patients.
FDA approves first biosimilar insulin product
Jul 29, 2021
Semglee (insulin glargine-yfgn) is biosimilar to and interchangeable with Lantus (insulin glargine), provides cost-effective option
Better strategies needed for managing NAFLD in adults
Jul 26, 2021
Needs assessment survey conducted in response to increasing clinical burden of nonalcoholic fatty liver disease, nonalcoholic steatohepatitis
Antidepressant use may aid outcomes in depression and diabetes
Jul 23, 2021
Regular versus poor antidepressant use tied to lower risk for advanced diabetic complications, mortality in patients with depression and diabetes
Cycling linked to reduced all-cause, CVD mortality in diabetes
Jul 20, 2021
Multivariable-adjusted hazard ratios for all-cause mortality reduced for one to 59, 60 to 149, 150 to 299, and ≥300 minutes/week
Using remote patient monitoring to improve resident health, staff satisfaction in LTC
By
Jamison Feramisco
Jul 22, 2021
Technology continues to play an increasingly important role in patient care. COVID-19 prompted many doctors to implement virtual care, sparking huge growth in telemedicine and remote patient monitoring....
Add-on PPI therapy may improve glycemic control in diabetes
Jun 28, 2021
However, treatment with proton pump inhibitors is not associated with risk for incident diabetes in the general population